Prof. Khalid Shah is the Professor at Harvard Medical School and directs the Center for Stem and Translational Immunotherapy (CSTI; https://csti.bwh.harvard.edu/). He is also the Principal Faculty at Harvard Stem Cell Institute in Boston. The potential of developing novel cancer therapies by him and his team has been recognized by many cancer alliances and associations. Based on this, he has received the young investigator award from Alliance for cancer gene therapy (ACGT), Research fellow award from American Cancer Society (ACS), Distinguished research award from Academy of Radiology and Innovation awards from James McDonnell Foundation, American Brain Tumor Association (ABTA) and Goldhirsh foundation.